What's new

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Mar 19, 2025 - 16:47
 0
Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Jayempi, azathioprine,...

Next Article

Some consumers confused about what organic means

Related Posts

Union Product Database: release notes

Union Product Database: release notes

Mar 5, 2025  0

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Summary of opinion: Darzalex, 27/02/2025 Positive

Summary of opinion: Darzalex, 27/02/2025 Positive

Feb 28, 2025  0